男女羞羞视频在线观看,国产精品黄色免费,麻豆91在线视频,美女被羞羞免费软件下载,国产的一级片,亚洲熟色妇,天天操夜夜摸,一区二区三区在线电影
Global EditionASIA 中文雙語Fran?ais
World
Home / World / Europe

China's Sinopharm COVID-19 vaccine safe, efficacious: WHO official

Xinhua | Updated: 2021-05-12 15:06
Share
Share - WeChat
A healthcare worker in North Macedonia handles China's Sinopharm coronavirus disease (COVID-19) vaccines at a sport centre, as the country continues its mass inoculation campaign, in Stip, North Macedonia May 6, 2021. [Photo/Agencies]

GENEVA - China's Sinopharm COVID-19 vaccines, very much used globally, have been considered both safe and efficacious, according to Mariangela Simao, World Health Organization (WHO) assistant director general for access to health products.

"We still have data proving that they are efficacious against severe disease," she said in a press conference on Monday. "Sinopharm has been very much used globally. I think 62 million doses have already been applied. It has been considered both safe and efficacious."

WHO Director-General Tedros Adhanom Ghebreyesus announced last week that China's Sinopharm COVID-19 vaccine has been validated for emergency use, marking the first Chinese vaccine officially recognized by the WHO.

The approval came after an extensive review by an external, technical advisor group that looked at different data, Simao added.

"We did site inspections in China in January and February... We accessed the clinical data available for Sinopharm. It was also considered suitable, and (with) efficacy and safety in good manufacturing practice," she noted.

She also mentioned that the WHO is committed to the COVAX Facility, which is "an equitable access mechanism that we are very much working on and striving to get enough doses to be distributed".

The official called for a change in the code of behavior, as many vaccine producers "are moving towards a profit-driven approach instead of an equitable-access approach".

"So (the) WHO is pushing very hard at the highest level for everyone who is manufacturing vaccines to consider putting those vaccines in a global mechanism that will ensure that all countries have access to them, not only high-income countries who can pay more for the vaccines, as we are seeing as we speak right now," Simao said.

"The code of behavior, when you talk about it, is not for vaccine nationalism. It is for everyone who has a product that can be a public health good and can help us in this acute phase of this pandemic," she stressed.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 武邑县| 临沂市| 长宁县| 柯坪县| 鹤壁市| 阜阳市| 隆昌县| 耒阳市| 营口市| 淮阳县| 罗田县| 昌宁县| 涿鹿县| 松溪县| 兖州市| 商南县| 白河县| 昭觉县| 金川县| 云和县| 象山县| 山东省| 邮箱| 兰考县| 沧源| 双峰县| 日喀则市| 肥西县| 荃湾区| 繁峙县| 增城市| 沙湾县| 和政县| 香港| 武鸣县| 金寨县| 乌兰浩特市| 甘孜县| 虞城县| 元氏县| 隆回县| 巴里| 嘉峪关市| 仁寿县| 石楼县| 遵义县| 东阳市| 黄骅市| 德昌县| 卢湾区| 宜川县| 隆安县| 澜沧| 万荣县| 宁武县| 贵溪市| 利辛县| 金湖县| 永清县| 县级市| 宜宾市| 武鸣县| 崇明县| 新兴县| 上饶市| 多伦县| 鄯善县| 四平市| 织金县| 龙江县| 腾冲县| 中江县| 襄垣县| 杂多县| 中西区| 都匀市| 正安县| 厦门市| 申扎县| 孟州市| 西藏| 闽清县|